Brent Billett

Brent Billett, PhD, is a Scientist specializing in ChemDev and CMC at Neurocrine Biosciences since January 2024. Previously, Brent served as a Senior Scientist in CMC at Zentalis Pharmaceuticals, where responsibilities included advancing small molecule therapeutics from discovery to clinic and enhancing synthetic routes. Brent's academic background includes a PhD from the University of Chicago, with research focused on synthetic studies of ent-kauranoid natural products with potential anti-cancer properties. Earlier roles included research and teaching assistant positions at The University of Texas at Austin and the University of Pittsburgh, along with laboratory technician experience at Graham Packaging, focusing on polymer research.